The FDA's Approach to the Prescription Opioid Problem

Our nation's ongoing prescription opioid abuse crisis, amounting to over 78 billion dollars in health and social costs annually,¹ is a critical priority for the US Food and Drug Administration (FDA). As a part of our mission to support the safe and effective use of prescription medicines, the FDA is taking a fresh look at potential scientific and regulatory actions we can take to address this crisis.